Substrate cycles and drug resistance to 1-beta-D-arabinofuranosylcytosine (araC).

Substrate cycles and drug resistance to 1-beta-D-arabinofuranosylcytosine (araC).

Item
http://www.wikidata.org/entity/Q35994964
Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia.Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes.Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.Anti-Cripto Mab inhibit tumour growth and overcome MDR in a human leukaemia MDR cell line by inhibition of Akt and activation of JNK/SAPK and bad death pathways.Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients.Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells.Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity.miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis.Creation of zebularine-resistant human cytidine deaminase mutants to enhance the chemoprotection of hematopoietic stem cells.
P2860

Substrate cycles and drug resistance to 1-beta-D-arabinofuranosylcytosine (araC).

Item
http://www.wikidata.org/entity/Q35994964
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Substrate cycles and drug resistance to 1-beta-D-arabinofuranosylcytosine (araC).
@ast
Substrate cycles and drug resistance to 1-beta-D-arabinofuranosylcytosine (araC).
@en
type
label
Substrate cycles and drug resistance to 1-beta-D-arabinofuranosylcytosine (araC).
@ast
Substrate cycles and drug resistance to 1-beta-D-arabinofuranosylcytosine (araC).
@en
prefLabel
Substrate cycles and drug resistance to 1-beta-D-arabinofuranosylcytosine (araC).
@ast
Substrate cycles and drug resistance to 1-beta-D-arabinofuranosylcytosine (araC).
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Substrate cycles and drug resistance to 1-beta-D-arabinofuranosylcytosine (araC)
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698